Skip to content

Tirzepatide: Dosage & Administration

Part of the Tirzepatide Complete Guide

Partner

Research Peptides

BioLongevity Labs15% Off
Shop Peptides at BioLongevity Labs

We may earn a commission if you purchase through this link, at no extra cost to you.

FDA-Approved Dosing Schedule

Tirzepatide (brand names Mounjaro for diabetes, Zepbound for weight management) uses a mandatory dose titration schedule. The 2.5 mg starting dose is a titration-only dose — it is not a therapeutic maintenance dose.

PhaseDoseDurationNotes
Starting2.5 mg weekly4 weeksTitration only — not a maintenance dose
First increase5 mg weekly4+ weeksFirst potential maintenance dose
Second increase7.5 mg weekly4 weeksTitration dose
Third increase10 mg weekly4+ weeksSecond potential maintenance dose
Fourth increase12.5 mg weekly4 weeksTitration dose
Maximum15 mg weeklyMaintenanceHighest FDA-approved dose

Key dosing principles:

  • Dose titration is mandatory. Starting at higher doses causes severe GI side effects. Each increase is 2.5 mg every 4 weeks minimum
  • Maintenance dose flexibility: Not everyone needs the maximum dose. Many patients achieve satisfactory results at 5 mg or 10 mg. Maintenance dose depends on individual response and tolerability
  • For diabetes (Mounjaro): Target dose is 5–15 mg based on glycemic control
  • For weight loss (Zepbound): Target dose is typically 10–15 mg for maximum weight loss

For comparison with semaglutide dosing, see tirzepatide vs semaglutide.

Administration & Injection Technique

Tirzepatide is administered as a once-weekly subcutaneous injection using pre-filled auto-injector pens:

  • Injection sites: Abdomen, thigh, or upper arm — rotate sites weekly to prevent lipodystrophy
  • Timing: Any day of the week, any time of day, with or without meals. Choose a consistent day each week
  • Day change: The injection day can be changed as long as the last dose was at least 3 days (72 hours) prior
  • Pen use: Each pen contains one dose. The pen is single-use and should be discarded after injection. The needle is hidden in auto-injector designs

Missed Dose Protocol

  • If within 4 days (96 hours) of the scheduled dose: administer as soon as possible
  • If more than 4 days late: skip the missed dose and resume on the next scheduled day
  • Resume the regular once-weekly schedule from the new day

Storage & Handling

FormStorageDuration
Unopened pensRefrigerate 2–8°C (36–46°F)Until expiration date
Unopened at room tempUp to 30°C (86°F)Up to 21 days, then discard
Do not freezeDiscard if frozen

Protect from light. Do not use if solution appears cloudy, discolored, or contains particles. For research-grade lyophilized tirzepatide, use the peptide calculator for reconstitution volumes and the storage guide for handling protocols.

Frequently Asked Questions

References

  1. Jastreboff AM, et al.. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 2022.
  2. Frias JP, et al.. Tirzepatide versus semaglutide once weekly in type 2 diabetes. New England Journal of Medicine, 2021.

Researching peptides? We did the hard part.

Get our free Peptide Starter Kit — the 5 most researched compounds, simplified into one actionable guide.

Related Guides

PI

Peptides Insider Editorial Team

Our content is reviewed for accuracy and grounded in peer-reviewed research where available. We do not provide medical advice. Always consult a qualified healthcare professional.